Karin Wåhlander

Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran

Sam Schulman, Karin Wåhlander, Torbjörn Lundström et al. · New England Journal of Medicine · 2003 · 457 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Increased Activity of L-Type Ca ²⁺ Channels Exposed to Serum from Patients with Type I Diabetes

Lisa Juntti‐Berggren, Olof Larsson, Patrik Rorsman et al. · Science · 1993 · 187 citations

Life Sciences, Cell Biology, Endocrinology +17

A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I

Henry Eriksson, Karin Wåhlander, David Gustafsson et al. · Journal of Thrombosis and Haemostasis · 2003 · 165 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Activation by adrenaline of a low-conductance G protein-dependent K+ channel in mouse pancreatic B cells

Patrik Rorsman, Krister Bokvist, Carina Ämmälä et al. · Nature · 1991 · 137 citations

Natural Sciences, Pharmacology, Physiology +14

Trousseau’s syndrome – what is the evidence?

David Bergqvist, Karin Wåhlander, Henry Eriksson et al. · Thrombosis and Haemostasis · 2006 · 99 citations

Medicine, Oncology, Cancer Epidemiology +16